Key facts
- An insider at Oruka Therapeutics sold 105,000 shares.
- The total value of the shares sold was $6.2 million.
- The transaction occurred on June 10, 2024.
Insider transactions can provide insights into a company's perceived value by those with non-public information. Significant sales by executives or directors may signal a belief that the stock is overvalued or that the insider needs liquidity.